Journals / Turkish Journal of Gastroenterology / 2018 / Cilt: 29 - Sayı: 1

The relationship of alanine aminotransferase to metabolic syndrome in a Korean population

Pages
52–60
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the longitudinal analyses, the prevalence of metabolic syndrome increased across serum alanine aminotransferase quartiles in a dose-dependent manner after extensive adjustments (hazard ratios were 1.000, 1.609, 2.601, and 3.015 for quartiles, 1 through quartile 4; P for trend<0.001).Conclusion: Our study confirmed a positive association between components of metabolic syndrome and elevated serum alanine ami-notransferase in a Korean population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Although associations between serum alanine aminotransferase and metabolic syndrome are well-recognized in Western countries, only a limited number of prospective studies have been performed in Asian populations.
📊
Key Findings & Data:The aim of the study was to cross-sectionally and longitudinally examine whether serum alanine aminotransferase levels are associated with metabolic syndrome and its associated components in a Korean population.Materials and Methods: A total of 31,832 subjects who received health screenings were included in cross-sectional analyses; a subgroup of 4.070 subjects without metabolic syndrome at baseline was included in the longitudinal analyses.
💡
Conclusion & Impact:In the longitudinal analyses, the prevalence of metabolic syndrome increased across serum alanine aminotransferase quartiles in a dose-dependent manner after extensive adjustments (hazard ratios were 1.000, 1.609, 2.601, and 3.015 for quartiles, 1 through quartile 4; P for trend<0.001).Conclusion: Our study confirmed a positive association between components of metabolic syndrome and elevated serum alanine ami-notransferase in a Korean population.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: Although associations between serum alanine aminotransferase and metabolic syndrome are well-recognized in Western countries, only a limited number of prospective studies have been performed in Asian populations. The aim of the study was to cross-sectionally and longitudinally examine whether serum alanine aminotransferase levels are associated with metabolic syndrome and its associated components in a Korean population.Materials and Methods: A total of 31,832 subjects who received health screenings were included in cross-sectional analyses; a subgroup of 4.070 subjects without metabolic syndrome at baseline was included in the longitudinal analyses. The metabolic syndrome definition was based on the National Cholesterol Education Program Third Adult Treatment Panel criteria with modification on waist circumfer-ence cut-off to be more appropriate for an Asian population.Results: In the cross-sectional analyses, serum alanine aminotransferase is positively associated with metabolic syndrome and its com-ponents. In the longitudinal analyses, the prevalence of metabolic syndrome increased across serum alanine aminotransferase quartiles in a dose-dependent manner after extensive adjustments (hazard ratios were 1.000, 1.609, 2.601, and 3.015 for quartiles, 1 through quartile 4; P for trend<0.001).Conclusion: Our study confirmed a positive association between components of metabolic syndrome and elevated serum alanine ami-notransferase in a Korean population.

🔖

Cite This Article

LEE, S., CHO, D., JOO, N., KİM, K. M., KIM, K. (2018). The relationship of alanine aminotransferase to metabolic syndrome in a Korean population. Turkish Journal of Gastroenterology, Cilt: 29 - Sayı: 1, 52–60. https://ajindex.com/articles/410142

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Schwartz MK. Clinical aspects of aspartate and alanine amino-transferases. Methods in Enzymology 1971
  2. [CrossRef] 29. Lee DH, Jacobs DR Jr, Gross M, et al. Gamma glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003
  3. [CrossRef] 28. Foroughi M, Maghsoudi Z, Khayyatzadeh S, Ghiasvand R, Askari G, Iraj B. Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver. Adv Biomed Res 2016
  4. [CrossRef] 27. Calcaterra V, Muratori T, Klersy C, et al. Early-onset metabolic syndrome in prepubertal obese children and the possible role of ala-nine aminotransferase as marker of metabolic syndrome. Ann Nutr Metab 2011
  5. [CrossRef] 26. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, et al. Fat ac-cumulation in the liver is associated with defects in insulin suppres-sion of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002
  6. Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005
  7. [CrossRef] 24. Garg A, Misra A. Hepatic steatosis, insulin resistance, and ad-ipose tissue disorders. J Clin Endocrinol Metab 2002
  8. Westerbacka J, Cornér A, Tiikkainen M, et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcu-taneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 2004
  9. [CrossRef] 22. Janičko M, Veselíny E, Orenčák R, et al. Redefining the alanine ami-notransferase upper limit of normal improves the prediction of met-abolic syndrome risk. Eur J Gastroenterol Hepatol 2015
  10. Kim HC, Choi KS, Jang YH, Shin HW, Kim DJ. Normal serum ami-notransferase levels and the metabolic syndrome: Korean National Health and Nutrition Examination Surveys. Yonsei Med J 2006
  11. [CrossRef] 20. Greenfield TK. Ways of measuring drinking patterns and the dif-ference they make: experience with graduated frequencies. J Subst Abuse 2000
  12. [CrossRef] 19. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005
  13. [CrossRef] 18. Executive Summary of the Third Report of the National Choles-terol Education Program (NCE